Eupraxia Pharmaceuticals Inc (EPRX)

Apr 04, 2026

Top iBio (IBIO) Competitors 2026 - MarketBeat

Apr 04, 2026

Apr 04, 2026

EPRX SEC FilingsEupraxia Pharmac 10-K, 10-Q, 8-K Forms - stocktitan.net

Apr 04, 2026

Apr 02, 2026

New strong sell stocks for April 2nd - msn.com

Apr 02, 2026

Mar 31, 2026

ETFs Investing in Eupraxia Pharmaceuticals, Inc. Stocks - TradingView

Mar 31, 2026

Mar 31, 2026

Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Mar 31, 2026

Mar 30, 2026

Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Short Interest Up 26.3% in March - MarketBeat

Mar 30, 2026

Mar 30, 2026

Eupraxia Pharmaceuticals Projected to Post Earnings on Tuesday - National Today

Mar 30, 2026

Mar 28, 2026

Eupraxia Pharmaceuticals boasts $900 million peak sales potential: Analyst - MSN

Mar 28, 2026

Mar 26, 2026

Risk Recap: What is Eupraxia Pharmaceuticals Incs valuation compared to sectorVolume Spike & Daily Chart Pattern Signals - baoquankhu1.vn

Mar 26, 2026

Mar 25, 2026

Aug Chart Watch: Whats the beta of Eupraxia Pharmaceuticals Inc stockMarket Movers & AI Enhanced Market Trend Forecasts - baoquankhu1.vn

Mar 25, 2026

Mar 24, 2026

Eupraxia Pharmaceuticals (EPRX) to Release Earnings on Tuesday - MarketBeat

Mar 24, 2026

Mar 23, 2026

Eupraxia Pharmaceuticals: Analyst Expects $900M In Peak SalesEupraxia Pharmaceuticals (NASDAQ:EPRX) - Benzinga

Mar 23, 2026

Mar 23, 2026

William Blair Initiates Coverage on Eupraxia Pharmaceuticals (NASDAQ:EPRX) - MarketBeat

Mar 23, 2026

Mar 23, 2026

Eupraxia Pharmaceuticals Inc.: Fundamental Analysis and Financial Ratings | X43 | CA29842P1053 - marketscreener.com

Mar 23, 2026

Mar 22, 2026

If You Invested $1,000 in Eupraxia Pharmac (EPRX) - stocktitan.net

Mar 22, 2026

Mar 19, 2026

You need to know this Canadian biotech stock, analyst says - Cantech Letter

Mar 19, 2026

Mar 19, 2026

Eupraxia Pharmaceuticals (NASDAQ:EPRX) Announces Earnings Results, Misses Estimates By $0.21 EPS - MarketBeat

Mar 19, 2026

Mar 19, 2026

Lifesci Capital Has Negative Outlook of EPRX FY2026 Earnings - MarketBeat

Mar 19, 2026

Mar 19, 2026

What is HC Wainwright's Estimate for EPRX Q1 Earnings? - MarketBeat

Mar 19, 2026

Mar 19, 2026

Eupraxia Pharmaceuticals (NASDAQ:EPRX) Stock Rating Lowered by Zacks Research - MarketBeat

Mar 19, 2026

Mar 18, 2026

Profit Recap: Will Eupraxia Pharmaceuticals Inc stock hit new highs in YEAR2026 Market WrapUp & AI Powered Buy and Sell Recommendations - baoquankhu1.vn

Mar 18, 2026

Mar 18, 2026

Q2 Earnings Estimate for EPRX Issued By HC Wainwright - MarketBeat

Mar 18, 2026

Mar 18, 2026

Eupraxia Pharmaceuticals (NASDAQ:EPRX) Given New $11.00 Price Target at HC Wainwright - Defense World

Mar 18, 2026

Mar 17, 2026

EPRX stock on retail radar after strong remission data in digestive disease trial - MSN

Mar 17, 2026

Mar 17, 2026

Buyout Rumor: Whats BioXcel Therapeutics Incs historical return2026 Trade Ideas & High Accuracy Swing Entry Alerts - baoquankhu1.vn

Mar 17, 2026

Mar 17, 2026

H.C. Wainwright cuts Eupraxia Pharmaceuticals price target on higher costs By Investing.com - Investing.com India

Mar 17, 2026

Mar 17, 2026

Eupraxia Pharmaceuticals Reports Six-Month Symptom Data from the Highest Dose Cohort in its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis - Investing News Network

Mar 17, 2026

Mar 17, 2026

Eupraxia Pharmaceuticals Stock Surges on Drug Trial Win - TipRanks

Mar 17, 2026

Mar 17, 2026

A Little-Known Biotech Is Gaining Retail Buzz With Its Latest Trial Data - Stocktwits

Mar 17, 2026

Mar 17, 2026

H.C. Wainwright cuts Eupraxia Pharmaceuticals price target on higher costs - Investing.com

Mar 17, 2026

Mar 17, 2026

EPRX Stock On Retail Radar After Strong Remission Data In Digestive Disease Trial - menafn.com

Mar 17, 2026

Mar 17, 2026

Eupraxia Pharmaceuticals Inc. - Baystreet.ca

Mar 17, 2026

Mar 17, 2026

HC Wainwright Has Lowered Expectations for Eupraxia Pharmaceuticals (NASDAQ:EPRX) Stock Price - MarketBeat

Mar 17, 2026

Mar 17, 2026

Eupraxia Pharmaceuticals Posts Strong Six-Month EoE Data for EP-104GI as RESOLVE Trial Advances - tipranks.com

Mar 17, 2026

Mar 17, 2026

Eupraxia (EPRX) shows strong symptom gains, clean safety in RESOLVE EoE trial - Stock Titan

Mar 17, 2026

Mar 17, 2026

Eupraxia Pharmaceuticals Reports Six-Month Symptom Data - GlobeNewswire

Mar 17, 2026

Mar 16, 2026

Freedman lifts Eupraxia (EPRX) stake to 9% after 2026 share purchases - Stock Titan

Mar 16, 2026

Mar 16, 2026

Aug Reactions: Is Eupraxia Pharmaceuticals Inc affected by consumer sentiment2026 Reactions & Community Consensus Trade Signals - baoquankhu1.vn

Mar 16, 2026

Mar 16, 2026

Short Interest in Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Rises By 19.4% - MarketBeat

Mar 16, 2026

Mar 15, 2026

Ally Bridge Group NY LLC Buys New Shares in Eupraxia Pharmaceuticals Inc. $EPRX - MarketBeat

Mar 15, 2026

Mar 14, 2026

(EPRX) Technical Data (EPRX:CA) - Stock Traders Daily

Mar 14, 2026

Mar 13, 2026

Cantor Fitzgerald Keeps Their Buy Rating on Eupraxia Pharmaceuticals (EPRX) - The Globe and Mail

Mar 13, 2026

Mar 13, 2026

Eupraxia Pharmaceuticals (NASDAQ: EPRX) files 2025 Form 40-F with audited statements - Stock Titan

Mar 13, 2026

Mar 12, 2026

Eupraxia Pharmaceuticals Reports Fourth Quarter 2025 Financial Results - Investing News Network

Mar 12, 2026

Mar 12, 2026

Eupraxia Widens Q4 Loss but Extends Cash Runway With $63 Million Financing - TipRanks

Mar 12, 2026

Mar 12, 2026

Eupraxia testing EoE drug extends cash runway to 2028 - Stock Titan

Mar 12, 2026